Restore
Lubricant Eye Drops
TheraTears® is clinically proven to reduce signs of symptoms of dry eyes
TheraTears® dry eye therapy is a hypotonic and electrolyte balanced formula that has been shown to reduce osmolarity over time.
TheraTears dry eye therapy is a hypotonic and electrolyte balanced formula that has been shown to reduce osmolarity over time
.
TheraTears dry eye therapy is a hypotonic and electrolyte balanced formula that has been shown to reduce osmolarity over time
TheraTears® provides immediate, long lasting dry eye relief for your patients in several formulas:
TheraTears® Dry Eye Therapy
- Immediate, long lasting relief of dry eye symptoms
- In clinical testing, consistent use provided homeostasis, reduced tear osmolarity and improved patient symptoms within as little as one week
- Improvement in visual acuity seen after 8 weeks
- Available in preservative-free vials and multi-dose bottles
TheraTears® EXTRA Dry Eye Therapy
- Up to 12 hours of hydrating comfort for your patients
- Relieves Irritation
- Rehydrates tear film
- Protects from further irritation
- Supports the homeostasis of tear film
- Available in preservative-free vials and multi-dose bottles
Learn More About Trehalose
Trehalose is a natural disaccharide with enhanced moisture retention capabilities1
Trehalose is used to enhance the effectiveness of active ingredients
In the U.S. as an excipient in at least four injectable pharmaceuticals2
TheraTears® Liquid Gel Nighttime Dry Eye Therapy®
- Soothing overnight relief of dry eye symptoms
- Unique hypotonic and electrolyte balanced formula replicates healthy tears
- Liquid-gel formula provides soothing, longer lasting relief and protection for nighttime use
- TheraTears® is just the right thickness to provide less blurring, non-crusting, protective film that is ideal for nighttime use
- Available in preservative-free, single-use vials (30 count)
1. Jones L, Downie L, Korb D, et al. TFOS Dews ll Management and Therapy Report. The Ocular Surface Jul 2017; 575-628.
2. Luyckx J, et al. Trehalose: An Intriguing Disaccharide with Potential for Medical Application in Ophthalmology. Clin Ophthalmol. 2011;5:577-581.